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ABSTRACT
Objectives: To explore changes over time in the 30-
day mortality rate for paediatric cardiac surgery and to
understand the role of attendant changes in the case
mix.
Methods, setting and participants: Included were:
all mandatory submissions to the National Institute of
Cardiovascular Outcomes Research (NICOR) relating to
UK cardiac surgery in patients aged <16 years. The
χ2 test for trend was used to retrospectively analyse
the proportion of surgical episodes ending in 30-day
mortality and with various case mix indicators, in
10 consecutive time periods, from 2000 to 2010.
Comparisons were made between two 5-year eras of:
30-day mortality, period prevalence and mean age for
30 groups of specific operations.
Main outcome measure: 30-day mortality for an
episode of surgical management.
Results: Our analysis includes 36 641 surgical
episodes with an increase from 2283 episodes in 2000
to 3939 in 2009 (p<0.01). The raw national 30-day
mortality rate fell over the period of review from 4.3%
(95% CI 3.5% to 5.1%) in 2000 to 2.6% (95% CI
2.2% to 3.0%) in 2009/2010 (p<0.01). The case mix
became more complex in terms of the percentage of
patients <2.5 kg (p=0.05), with functionally
univentricular hearts (p<0.01) and higher risk
diagnoses (p<0.01). In the later time era, there was
significant improvement in 30-day mortality for arterial
switch with ventricular septal defect (VSD) repair,
patent ductus arteriosus ligation, Fontan-type
operation, tetralogy of Fallot and VSD repair, and the
mean age of patients fell for a range of operations
performed in infancy.
Conclusions: The raw 30-day mortality rate for
paediatric cardiac surgery fell over a decade despite a
rise in the national case mix complexity, and compares
well with international benchmarks. Definitive repair is
now more likely at a younger age for selected infants
with congenital heart defects.
INTRODUCTION
There has been strong interest in the
outcome of paediatric cardiac surgery in the
UK since the 1990s, when a high mortality
rate was disclosed at one centre,1 and contin-
ued scrutiny recently in the context of a pro-
posed national reconﬁguration of services.2
Mandatory national audit was introduced in
1997, all specialist centres have contributed
data since 2000, and centre-speciﬁc out-
comes for individual procedure types have
been published online since 2005.3 The UK
is one of only three countries with universal
KEY MESSAGES
What is already known about this subject?
▸ There is a high level of public interest in the out-
comes of paediatric cardiac surgery.
▸ The focus of this interest has been on the
merits and difficulties of comparing outcomes
between different units, with little attention on
raw mortality at a national level.
▸ Understanding of the factors underpinning
short-term surgical risk for paediatric cardiac
surgery has improved in recent years.
What does this study add?
▸ While the number of procedures performed
nationally in the UK has increased over the last
decade, the 30-day mortality rates for paediatric
cardiac surgery have fallen. Mortality rates are
low and compare favourably with current data
from other international databases.
▸ The improvement in short-term outcomes is not
explained by lower risk case mix, since data
indicate that the children operated on have
increased in complexity.
▸ There has been a trend towards earlier definitive
repair in infancy for a range of conditions in the
recent era.
How might this impact on clinical practice?
▸ The very low mortality rates at 30 days must
shift our focus now towards measures of mor-
bidity, longer term survival and functional out-
comes, which, although of great importance to
patients and their families, are less well deli-
neated and, furthermore, may provide evidence
on the comparative long-term benefits of differ-
ent surgical strategies and models of care.
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participation in national audit of paediatric cardiac
surgery, the other two being Sweden and Poland,
meaning that the UK Congenital Heart Audit is a valu-
able resource for the evaluation of outcomes.
Outcomes were not initially included in the Safe and
Sustainable Review of paediatric cardiac services,2
because fair adjustment for case mix was considered too
difﬁcult to achieve. Paediatric cardiac surgery is very het-
erogeneous, with several thousand individual codes
(International Paediatric and Congenital Cardiac Code
(IPCCC)4) used in combinations to describe the under-
lying congenital heart disease (CHD); and the risk for
each speciﬁc procedure varies widely.5 Early efforts to
adjust for case mix were based on the subjective assess-
ment of risks by panels of experts,6 7 but recent empiric
risk adjustment methods have been based on the ana-
lyses of records collected within audit databases.8 9 The
recent development of a UK-based risk adjustment
model (PRAiS, partial risk adjustment in surgery), for
the purpose of routine monitoring of outcomes by clin-
ical teams, identiﬁed components of case mix associated
with 30-day mortality for paediatric cardiac surgery
including functionally univentricular heart,10 lower
weight, younger age and certain underlying CHDs and
procedure types.8 10
This study aimed to evaluate trends in the raw 30-day
mortality rate for UK paediatric cardiac surgery proce-
dures over the last decade, and to explore to what
extent any trend might be explained by attendant
changes in the complexity of case mix.
METHODS
The ofﬁcers of the Bloomsbury Research Ethics
Committee (REC) deemed that the study did not
require review by the REC.
The data set
The pseudoanonymised data set consisted of records of
cardiac surgical operations in patients under the age of
16 years conducted in the UK before 31 December
2010. Prior to analyses being undertaken, records with
missing outcome or age, and records of non-cardiac pro-
cedures from a minority of centres submitting before
year 2000 and in very small numbers from adult centres,
were removed.
The survival status for English and Welsh patients was
independently conﬁrmed through periodic requests to
the Central Register of National Health Service (NHS)
patients, as approved by the National Information and
Governance Board for Health and Social Care. In
Scotland, Northern Ireland and the private sector, the
specialist centres veriﬁed the outcome of their own
patients. Consent was requested from parents for submis-
sion of their child’s data for national audit of outcomes.
The unit of analysis and outcome measure
To obviate ambiguities in assigning short-term outcomes
to operations performed close together in time, we
deﬁned 30-day episodes of surgical management. The
ﬁrst such episode for a patient started with his or her
ﬁrst surgical operation and was assigned an outcome of
alive or dead according to the vital status of the patient
at 30 days, whether or not a reintervention occurred
during the 30-day episode—this represented the main
outcome measure for the study.
Case mix
Case complexity was analysed based on the following
factors, all of which have been shown to be associated
with 30-day mortality8
1. High risk primary CHD types—hypoplastic left heart
syndrome, pulmonary atresia with intact ventricular
septum or interrupted aortic arch, deﬁned based on
a hierarchical mapping of IPCC diagnostic codes, up
to six of which were available for each episode.10
2. Univentricular heart—those combinations of IPCC
codes that indicated a patient with a functionally uni-
ventricular heart.10
3. Age at operation—neonate (≤30 days), infant (31 days–
1 year) or child (>1 year), younger age being highest
risk.8
4. Weight at operation, with low weight deﬁned as less
than 2.5 kg.11
5. Multivariate risk—one of four bands based on the esti-
mated risk of death for an individual episode calcu-
lated using a bespoke calibration of the PRAiS risk
model8 that excluded information on comorbidity
(because of changing data quality over the study
period) and era of surgery (to allow analysis of this
effect). The bands used were: band 1—less than 1%
estimated risk of death; band 2—cases with estimated
risk between 1% and up to 3%; band 3—cases with
between 3% and 10% estimated risk and band 4—
cases with over 10% estimated risk.
6. Speciﬁc procedure types—the steering committee of the
congenital heart audit have developed an algorithm
that links the combinations of up to six individual
IPCC procedure codes in a record to 1 of 38 recog-
nisable operations3 including generally accepted
‘benchmark operations’12 along with others. Each
surgical episode in the data set was assigned to either
a speciﬁc procedure according to this algorithm, or
to a set of ungrouped procedures (‘not a speciﬁc pro-
cedure’). Within the 38 speciﬁc procedures, a group
of 10 procedures with less than 100 instances each
was combined into a single group referred to as the
‘low volume group’.8
Analysis
The number of episodes, raw mortality rate and the case
mix were assessed within the study cohort using a calen-
dar year as the unit for comparison. The year 2010 con-
tained a truncated amount of data corresponding to
around half of the cases for that calendar year, related
to the date on which the data were harvested, therefore
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the years 2009/2010 were combined for analyses, except
the count of procedures per calendar year.
The 30-day mortality rate, the 30-day mortality rate
within risk bands and the prevalence of categorical
aspects of case mix were explored using χ2 test for trend
by calendar year. We tabulated these analyses (table 1),
reporting in the text the percentage or rate for the ﬁrst
and the last calendar year, with 95% conﬁdence interval
(CI) and χ2 test for trend p value.
A secondary analysis involving speciﬁc procedure
groups was performed based on two eras (2000–2004
inclusive and 2005–2010 inclusive). The low number of
episodes for some procedure groups did not support
analysis for each calendar year. The 30-day mortality for
each speciﬁc procedure group was compared between
eras based on odds ratio (OR). The relative frequency
for each speciﬁc procedure group was compared
between eras, and the distribution of procedures by era
was reviewed qualitatively. The difference in mean age at
operation was calculated, compared between eras, and
tested for signiﬁcance using a t test. No corrections were
made for multiple hypotheses testing.
RESULTS
Of 38 597 episodes, we removed 919 (2.4%) with
missing outcome (see table 1), 10 episodes involving
non-cardiac procedures, 53 episodes with missing age,
930 episodes from two centres that alone submitted data
prior to 2000 and 44 episodes pertaining to older chil-
dren operated in non-paediatric specialist centres. The
data set used for analyses consisted of 36 641 episodes
corresponding to 30 041 unique patients, of whom
24 899 had 1 surgical episode and 5142 underwent 2 or
more surgical episodes. Of 36 641 surgical episodes,
1626 (4.4%) involved at least one reoperation and
35 015 (95.6%) of episodes consisted of only one surgi-
cal procedure.
There was a marked increase in the number of pro-
cedure episodes per completed calendar year from 2283
in 2000 to 3939 in 2009 (p<0.01; see ﬁgure 1). The raw
mortality rate fell signiﬁcantly and consistently over the
period of review from 4.3% (95% CI 3.5% to 5.1%) in
2000 to 2.6% (95% CI 2.2% to 3.0%) in 2009/2010
(p<0.01).
Risk bands
The proportion of patients within each risk band by cal-
endar year is shown in ﬁgure 2 and the corresponding
mortality rates are shown in ﬁgure 3. While there was an
increase in case volume across all risk bands, this was
least pronounced in risk band 1 (lowest risk). Within
band 1, the mortality rate fell from 1.4% (95% CI 0.6%
to 2.1%) in 2000 to 0.5% (95% CI 0.2% to 0.7%) in
2009/2010 with strong evidence for a trend (p<0.01).
Although not statistically signiﬁcant, 30-day mortality fell
in band 2 from 3.2% (95% CI 1.9% to 4.5%) to 1.6%
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(95% CI 1.1% to 2.2%; p=0.09) and in band 3 from
11.1% (95% CI 8.1% to 14.3%) to 4.5% (95% CI 3.6%
to 6.0%; p=0.08). In band 4 (highest risk), the 30-day
mortality rate was similar over the period of review:
10.3% (95% CI 9.5% to 15.2%) in 2000 and 12.7%
(9.5% to 15.8%) in 2009/2010 (p=0.58).
Case mix
There was evidence for an overall rise in case complexity
over the period of review (ﬁgure 4). The proportion of
low weight babies increased from 8.1% (6.9% to 9.3%)
in 2000 to 10.4% (95% CI 9.6% to 11.1%) in 2009/2010
(p=0.05); the proportion of surgical episodes in patients
with functionally univentricular hearts increased from
13.2% (95% CI 11.8% to 14.6%) in 2000 to 16.3% (95%
CI 15.4% to 17.3%) in 2009/2010 (p<0.01), and the
proportion of surgical episodes for patients with higher
risk diagnoses (hypoplastic left heart syndrome, pulmon-
ary atresia or interrupted aortic arch) increased from
6.7% (95% CI 5.6% to 7.7%) in 2000 to 9.5% (95% CI
8.7% to 10.2%) in 2009/2010 (p<0.01). There was not a
signiﬁcant trend in the proportion of episodes in risk
band 4, at 6.8% (95% CI 5.8% to 7.8%) in 2000 and
7.2% (95% CI 6.6% to 7.9%) in 2009/2010 (p=0.60).
The proportion of surgical episodes in neonates
remained similar over the period of review, at 23.7%
(95% CI 21.9% to 25.4%) in 2000 and 20.9% (19.9% to
22.0%) in 2009/2010 (p=0.49).
The proportion of episodes that were in infants
increased from 35.6% (95% CI 33.7% to 37.6%) in 2000
to 39.3% (95% CI 38.0% to 40.5%) in 2009/2010
(p<0.01), with a contemporaneous fall in childhood
operations from 40.7% (95% CI 38.7% to 42.7%) in
2000 to 39.8% (95% CI 38.6% to 41.1%) in 2009/2010
(p<0.01).
Specific procedure groups
Mortality rates for speciﬁc procedure groups by each
5-year time period (2005–2010 inclusive compared with
2000–2004) are shown in ﬁgure 5. We list in this section
results from the analysis of 30-day mortality for speciﬁc
procedure groups signiﬁcant at p≤0.5 (note no correc-
tions were made for multiple hypotheses testing). The
OR of 30-day mortality for the later era, period preva-
lence by era and difference in mean age at surgery by
era, can be found in table 2.
There was evidence of signiﬁcantly lower 30-day mor-
tality in the later era for six speciﬁc procedure groups:
arterial switch operation with ventricular septal defect
(VSD) repair, ligation of patent ductus arteriosus (PDA),
the ‘no speciﬁc procedure’ group, the Fontan-type oper-
ation, tetralogy of Fallot repair and isolated VSD repair.
There was evidence for signiﬁcantly higher 30-day mor-
tality for only one speciﬁc operation type in the later
era: the systemic to pulmonary arterial shunt.
Figure 1 UK paediatric cardiac surgery mortality rate by year for all cases and total number of procedures performed between
2000 and 2009/2010. Figure shows observed annual paediatric cardiac surgery case numbers for each completed year between
2000 and 2009 (presented as a single year in this instance) and national unadjusted 30-day mortality with 95% CI by year
between 2000 and 2009/2010.
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DISCUSSION
In the context of a large increase in the number of pro-
cedures submitted annually for audit, the raw 30-day
mortality rate for paediatric cardiac surgical episodes in
the UK fell from 4.3% in 2000 to 2.6% in 2009/2010,
with a downward trend over this period. The drop in
30-day mortality was seen across the lower three bands of
risk, which accounted for 92.9% of surgical episodes,
but not in the highest risk band. Interestingly, the UK
paediatric cardiac surgery case mix has become more
rather than less complex over a decade of improving
outcomes as reﬂected by the increased prevalence of
functionally univentricular hearts, high-risk diagnoses
and low weight at operation (<2.5 kg). This trend sug-
gests that rather than turning away higher risk patients
during an era when outcomes have been monitored
more closely, conversely, a greater proportion of more
complex patients were taken on in later years.
There was evidence that deﬁnitive surgical repairs are
being performed earlier in life than was previously the
case, with a lower age at operation in the later era, for
several procedures applicable to babies and small
children: complete atrioventricular septal defect repair,
VSD repair, tetralogy of Fallot repair, coarctation repair,
subaortic stenosis repair and Rastelli procedure. This is
in keeping with selected single centre reports, advocat-
ing the safety of earlier repair in complete atrioventricu-
lar septal defect13 and tetralogy of Fallot.14 Moreover, it
is consistent with a decrease in the relative frequency of
palliative arterial shunts in lieu of deﬁnitive repair and a
younger age at operation among arterial shunt patients.
Higher 30-day mortality among the residual smaller
group of patients undergoing arterial shunt in the later
era relates to greater complexity (mean multivariate risk
increased in era 2 for shunt patients, data not shown) as
has been observed in other published data.15
The increase in the relative frequency of the Norwood
operation, arterial switch with VSD repair, PDA ligations
(a procedure performed predominantly for premature
babies) and bidirectional cavopulmonary shunt (also
occurring at younger age), as shown in table 2, is consist-
ent with a more proactive approach nationally to the
treatment of small babies with more complex conditions,
tying in with our ﬁnding of a greater proportion of
Figure 2 UK trends in paediatric cardiac surgery case volume analysed by risk band between 2000 and 2009. Figure shows
observed annual paediatric cardiac surgery case numbers for each completed year between 2000 and 2009 (presented as a
single year in this instance) divided by the risk band of each surgical episode. Risk band 1—less than 1% estimated risk of
death; band 2—cases with estimated risk between 1% and up to 3%; band 3—cases with between 3% and 10% estimated risk
and band 4—cases with over 10% estimated risk.
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operations at low weight. The Norwood operation fell
into the highest risk band 4, and although the UK
Norwood outcomes compare well with other
Registry-based data,9 there was no improvement in band
4 outcomes over the period of review. We note that
mean multivariate risk increased among risk band 4 over
time (data not shown). Furthermore, we were unable to
include comorbidity information in our study because of
data quality issues: in the most recent data reported by
the National Institute of Cardiovascular Outcomes
Research (NICOR) for 2009/2012, the rate of comorbid
conditions was the highest ever reported at 30%,16 and
while this may represent improved capture of this
element, there may also be a true increase in comorbid-
ity over time, with such babies prevalent in risk band 4.
A wider acceptance of very complex patients for surgical
management may have mitigated the effects of improve-
ments in care, which more obviously beneﬁted other
patient groups in terms of the reported improvements
in outcome for lower risk patients.
The number of procedures performed per annum
increased over the period of review, with the smallest pro-
portionate increase in risk band 1 cases (see ﬁgure 2),
which were relatively static in terms of annual case
volume from 2003 onwards. A relatively small rise in the
number of incident cases of CHD in the UK has been
reported over the same era,17 therefore the increase in
national case volume supports the hypothesis of a more
proactive approach towards surgical treatment of CHD
and greater likelihood of early survival among surgically
treated patients who require serial operations over their
life time.
Strengths and weaknesses of the study
The mandatory submission of data for national audit of
paediatric cardiac surgery in the UK and the data
quality assurance processes employed by NICOR to
promote full and standardised reporting of surgical
activity is a considerable strength for this study. That
said, as for any study based on retrospective observa-
tional data, conclusions must be viewed in the context of
limitations to data quality. As stated in the results, epi-
sodes with missing outcome (919, 2.4% of episodes in
the original dataset) were removed. The distribution of
missing outcome (table 1) was concentrated at the start
and at the end of the period of review, which is
explained by process issues in 2000–2002 and the
harvest of the data before complete ascertainment of
outcome could be performed for 2009/2010. Between
the years 2003 and 2008, the level of missing outcome
was 0% and 0.4%, and therefore unlikely to render
inaccurate the reported national mortality rate between
these years. As stated, due to the poor level of complete-
ness of comorbidity data and changes in this aspect over
time, we were unable to include this in the study. Given
the role of NICOR in audit of centre-speciﬁc outcomes
Figure 3 UK trends in paediatric cardiac surgery case mortality rate analysed by risk band between 2000 and 2009/2010.
Figure shows the national unadjusted 30-day mortality with 95% CI by year between 2000 and 2009/2010 divided by the risk
band of each surgical episode. Risk band 1—less than 1% estimated risk of death; band 2—cases with estimated risk between
1% and up to 3%; band 3—cases with between 3% and 10% estimated risk and band 4—cases with over 10% estimated risk.
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and the study objective of evaluating national trends, the
research team did not seek permission to perform ana-
lyses of outcomes within individual centres.
Study data in context
Outcomes of improved mortality in paediatric cardiac
surgery, attributed to surgical techniques and intensive
care practices, have been reported previously from the
USA.18 The North American paediatric cardiac surgery
audit database ‘STS-CHSDB’ recently published the dis-
charge mortality rate for the 85 participating centres
between 2005 and 2009 at 4.1% (3309 of 81 062 surgery
admissions).19 We note that discharge mortality is differ-
ent from 30-day mortality since it contains longer stay
patients, and therefore the two are not directly compar-
able. The European Association for Cardiothoracic
Surgery (EACTS) database currently posts 16 578 proce-
dures in 14 501 patients for 2009, with a 4.01% 30-day
mortality, which is a reduction from 4.26% 30-day mor-
tality for 2008.20 Although having wide coverage, submis-
sion of data is not mandatory and neither of these large
multi-institutional databases is completely representative
of national or regional outcomes. Furthermore, only a
small proportion of centres submitting data to these
registries are validated, whereas there are independent
annual validation visits in UK centres.21
Across these studies, there are differences in how early
postoperative outcomes are deﬁned and attributed. Our
study is based on 30-day status, which in comparison
with discharge status has the advantage of being inured
to differences in institutional discharge and referral pro-
tocols. However, with increased capability to prolong life
in intensive care, survival to 30-days is arguably a less
robust measure of successful early outcome than it once
was. Also, it should be noted that the analysis we report
is based on outcomes for 30-day surgical episodes and
not at the level of each visit to theatre by a patient.
The history of paediatric cardiac surgery in the UK is
such that the specialty is highly scrutinised and con-
nected in the public mind to troubling past events.1 22 The
results reported in this paper reﬂect the national early sur-
gical outcomes over a period where the specialty has been
subject to a far reaching review: the ‘Safe and sustainable
review of paediatric cardiac surgery’.2 This process led to
exploration of every aspect of paediatric cardiac care in
each centre nationally, and while negative views on the safe
and sustainable review process have been expressed, it may
be the case that the detailed critique and suggestions for
improvement by a panel of experts did contribute to
improvements in quality both locally and nationally. The
very low mortality rates at 30 days must shift our focus now
towards measures of morbidity, longer term survival
Figure 4 UK trends in selected aspects of paediatric cardiac surgery case mix between 2000 and 2009/2010. Figure shows
selected aspects of the national case mix related to all paediatric cardiac surgery cases for each year between 2000 and 2009/
2010 shown as a proportion with 95% CI. These are operations in patients with functionally univentricular hearts (triangle);
operations performed in patients with underlying higher risk congenital heart disease types (diamond), include hypoplastic left
heart syndrome, pulmonary atresia with intact septum and interrupted aortic arch; operations in babies weighing <2.5 kg (square)
and cases in risk band 4 (circle).
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outcomes (such as survival to 90 days or 1 year) and func-
tional outcomes, which, although of great importance to
patients and their families, are less well delineated, and fur-
thermore may provide evidence on the comparative long-
term beneﬁts of different surgical strategies and models of
care. The patient groups where improvements in outcome
have not been observed, including babies undergoing
shunts and the most complex children in risk band 4,
warrant further more detailed audit, in order to establish
whether further lessons may be learned.
Figure 5 UK paediatric cardiac surgery 30-day mortality rates for individual specific procedures by era (2000–2004 compared
with 2005–2010). Figure shows observed 30-day mortality for specific procedure groups in the first era 2000–2004 (circles) and
the second era 2005–2010 (crosses) with 95% CI (bars). The vertical lines denote the mean 30-day mortality in the first era
(black continuous, representing 3.4%) and the second era (blue dashed, representing 2.9%). Data are ordered in decreasing
30-day mortality for the first era 2000–2004. The low-volume procedure group (n=528, 1.4% of operations performed) includes
aortic root replacement (not Ross), aortopulmonary window repair, atrioventricular septal defect and tetralogy repair, cor
triatriatum repair, multiple VSD closure, Senning or Mustard procedure, tetralogy with absent pulmonary valve repair, total
anomalous pulmonary venous connection repair plus arterial shunt, tricuspid valve replacement and truncus with interrupted
aortic arch repair. The ‘not a specific procedure’ group contains all bypass and non-bypass cardiac operations that did not fall
into a defined group: 6791 (18.5%) operations performed. VSD, ventricular septal defect; PDA, patent ductus arteriosus; AVR,
aortic valve replacement; ASD, atrial septal defect.
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Table 2 (Landscape): Specific procedure groups expressed in terms of the total number, the OR of 30-day mortality in the later era (2005–2010), the period prevalence
as a percentage of total cases in the first (2000–2004) and second era (2005–2010), and the difference in mean age between era 1 (2000–2004) and era 2 (2005–2010)
Specific procedure (ranked
in order of 30-day mortality
for era 1) Number
OR of 30-day mortality for
era 2 (95% CI)
Period prevalence as a
percentage for era 1
(95% CI)
Period prevalence as a
percentage for era 2
(95% CI)
Mean age (years) difference:
era 1 minus era 2 (95% CI)
Norwood procedure 931 1.03 (0.73 to 1.46) 2.3 (2.0 to 2.5) 2.8 (2.6 to 3.0) 0.02 (−0.02 to 0.05)
Aortic valvotomy 198 0.58 (0.18 to 1.84) 0.6 (0.5 to 0.7) 0.5 (0.4 to 0.6) −0.63 (−1.95 to 0.69)
Mitral valve replacement 272 1.06 (0.41 to 2.71) 0.7 (0.6 to 0.9) 0.7 (0.6 to 0.9) −1.4 (−2.6 to −0.18)
Interrupted aortic arch repair 260 0.77 (0.30 to 1.96) 0.8 (0.8 to 0.9) 0.7 (0.6 to 0.8) 0.01 (−0.23 to 0.25)
Truncus arteriosus repair 276 0.78 (0.31 to 1.96) 0.7 (0.6 to 0.8) 0.8 (0.7 to 0.9) −0.17 (−0.44 to 0.10)
Arterial switch+VSD closure 428 0.30 (0.11 to 0.80) 0.8 (0.7 to 1.0) 1.4 (1.2 to 1.5) 0.04 (−0.15 to 0.24)
Total anomalous pulmonary
veins repair
644 0.90 (0.45 to 1.78) 2.0 (1.8 to 2.2) 1.6 (1.4 to 1.8) 0.14 (−0.08 to 0.36)
Arterial shunt 2436 1.60 (1.17 to 2.20) 7.6 (7.2 to 8.0) 5.9 (5.6 to 6.2) 0.35 (0.20 to 0.50)
Isolated pulmonary artery band 1138 1.01 (0.59 to 1.74) 2.9 (2.6 to 3.1) 3.3 (3.0 to 3.5) 0.03 (−0.17 to 0.23)
PDA ligation 3012 0.56 (0.39 to 0.82) 7.7 (7.3 to 8.1) 8.6 (8.2 to 9.0) 0.27 (−0.01 to 0.62)
Anomalous coronary artery
repair
137 0.48 (0.07 to 3.51) 0.3 (0.2 to 0.4) 0.4 (0.3 to 0.5) −1.16 (−2.41 to 0.08)
Low volume group 288 1.37 (0.64 to 2.93) 1.5 (1.3 to 1.6) 1.5 (1.3 to 1.6) 0.29 (−0.52 to 1.10)
Pulmonary atresia VSD repair 296 0.80 (0.23 to 2.81) 0.8 (0.7 to 1.0) 0.8 (0.7 to 0.9) 0.71 (−0.04 to 1.46)
No specific procedure 6791 0.75 (0.58 to 0.98) 17.5 (16.9 to 18.1) 19.3 (18.8 to 19.9) 0.28 (0.69 to 0.50)
Fontan-type procedure 1610 0.45 (0.23 to 0.89) 5.2 (4.8 to 5.5) 3.8 (3.5 to 4.1) −1.04 (−1.34 to −0.74)
Pulmonary valve replacement 381 0.34 (0.07 to 1.53) 0.8 (0.6 to 0.9) 1.3 (1.1 to 1.4) −0.31 (−1.41 to 0.77)
Arterial switch 1393 0.51 (0.26 to 1.04) 4.0 (3.7 to 4.3) 3.6 (3.4 to 3.9) 0.03 (−0.02 to 0.08)
Aortic valve replacement 210 1.13 (0.18 to 6.90) 0.6 (0.5 to 0.7) 0.6 (0.5 to 0.7) −0.47 (−1.50 to 0.56)
Tetralogy repair 2359 0.44 (0.21 to 0.91) 6.6 (6.2 to 7.0) 6.3 (6.0 to 6.7) 0.22 (0.09 to 0.34)
Atrioventricular septal defect
(complete) repair
1357 0.78 (0.36 to 1.70) 3.5 (3.2 to 3.7) 3.9 (3.6 to 4.2) 0.25 (0.05 to 0.45)
Rastelli procedure 190 0.40 (0.04 to 4.48) 0.5 (0.4 to 0.7) 0.5 (0.4 to 0.6) 1.59 (0.76 to 2.41)
Heart transplant 528 1.34 (0.24 to 7.44) 0.6 (0.5 to 0.7) 0.7 (0.6 to 0.8) 1.32 (−0.04 to 2.69)
Bidirectional cavopulmonary
shunt
1495 2.19 (0.84 to 5.74) 2.8 (2.5 to 3.0) 5.1 (4.8 to 5.4) 0.37 (0.12 to 0.62)
Isolated coarctation repair 2243 0.79 (0.38 to 1.64) 7.0 (6.6 to 7.4) 5.5 (5.2 to 5.8) 0.33 (0.07 to 0.59)
Ross operation 402 0.47 (0.04 to 5.21) 1.2 (1.1 to 1.4) 1.0 (0.8 to 1.1) −0.57 (−1.49 to 0.36)
Subvalvar aortic stenosis repair 825 0.98 (0.30 to 3.24) 2.3 (2.1 to 2.6) 2.2 (2.0 to 2.4) 0.76 (0.17 to 1.35)
Ventricular septal defect repair 3583 0.22 (0.09 to 0.56) 10.0 (9.6 to 10.5) 9.6 (9.2 to 10.0) 0.19 (0.001 to 0.38)
Supravalvar aortic stenosis
repair
220 2.26 (0.23 to 22.16) 0.6 (0.5 to 0.7) 0.6 (0.5 to 0.7) 0.98 (−0.10 to 2.07)
ASD repair 2053 0.83 (0.12 to 5.89) 5.9 (5.5 to 6.3) 5.4 (5.1 to 5.7) 0.17 (−0.15 to 0.48)
Atrioventricular septal defect
(partial) repair
725 1.84 (0.17 to 20.39) 2.2 (2.0 to 2.4) 1.8 (1.6 to 2.0) 0.47 (−0.06 to 1.01)
Data highlighted in bold all have p<0.05 for the test statistic: OR, difference in proportions, differences in means.
ASD, atrial septal defect; PDA, patent ductus arteriosus; VSD, ventricular septal defect.
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